Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

2.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.9K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

554
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
554

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Conserved macromolecular architecture of poplar secondary cell walls revealed by ssNMR and atomistic modeling.

Nature communications·2026
Same author

Chemically Robust, Primary Amine Rich Mussel-Inspired Nanoscale Coatings via a Cation-π Interaction Independent Pathway.

ACS applied materials & interfaces·2026
Same author

A Dynamic NMR Lineshape Simulation Framework for Lipid Diffusion and Membrane Thinning in Bicelles and Nanodiscs.

The journal of physical chemistry. B·2026
Same author

Reversible color switching of bright phosphorescence in purely organic materials for advanced data encryption.

Nature communications·2026
Same author

Molecular Mechanisms Governing Peptide Nanodisc Assembly and Stability.

bioRxiv : the preprint server for biology·2026
Same author

From overlap to resolution: Cellular solid-state NMR at ultrahigh-field 1.5 GHz demonstrated on fungal cell walls.

Solid state nuclear magnetic resonance·2026
Same journal

Ti/Sr Gradient Doping with SrTiO<sub>3</sub> Coating for Mitigating Strain and Oxygen Loss in Ni-Rich Cathode.

ACS applied materials & interfaces·2026
Same journal

Metallic Lead to Perfect Perovskite: A Bottom-Up Vapor-Assisted Colloidal Strategy for High-Performance Solar Cells.

ACS applied materials & interfaces·2026
Same journal

Two-Dimensional VSe<sub>2</sub>@Polypyrrole Heterostructure Enables Stable High-Rate Lithium-Sulfur Batteries.

ACS applied materials & interfaces·2026
Same journal

A Multifunctional Hydrogel Integrating Hemostatic, Antioxidant, and Antibacterial Properties for Infected and Diabetic Wound Regeneration.

ACS applied materials & interfaces·2026
Same journal

Tunable Interfacial to Filamentary Resistive Switching Mechanism in Room-Temperature-Grown Amorphous YBa<sub>2</sub>Cu<sub>3</sub>O<sub><i>x</i></sub> with Excess Cu Addition.

ACS applied materials & interfaces·2026
Same journal

Bioinspired Rhombic VO<sub>2</sub> Metasurface with Low Solar Absorptance for Self-adaptive All-Weather Building Thermal Management.

ACS applied materials & interfaces·2026
查看所有相关文章

相关实验视频

Updated: Jun 24, 2025

Genetic Incorporation of Biosynthesized L-dihydroxyphenylalanine DOPA and Its Application to Protein Conjugation
10:24

Genetic Incorporation of Biosynthesized L-dihydroxyphenylalanine DOPA and Its Application to Protein Conjugation

Published on: August 24, 2018

7.9K

聚多巴胺粘附:甲基醇,氨基,二氧化和聚合动力学.

Jiwon Lim1,2, Shuo Zhang1,2, Jung-Moo Heo2,3

  • 1Macromolecular Science and Engineering, University of Michigan, 2800 Plymouth Road, Ann Arbor, Michigan 48109, United States.

ACS applied materials & interfaces
|June 5, 2024
PubMed
概括
此摘要是机器生成的。

聚多巴胺 (PDA) 粘附源于不溶性聚合物形成,而不是特定结合. 氨基因对于这种聚合至关重要,使PDA成为可能.

关键词:
粘附性 粘附性 粘附性 粘附性卡特科胺氨基酸的使用.涂层涂层是一种涂层.聚多巴胺胺是一种多多巴胺胺.聚醇是一种多醇.表面功能化的功能化.

更多相关视频

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles
07:58

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles

Published on: November 14, 2018

8.2K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.7K

相关实验视频

Last Updated: Jun 24, 2025

Genetic Incorporation of Biosynthesized L-dihydroxyphenylalanine DOPA and Its Application to Protein Conjugation
10:24

Genetic Incorporation of Biosynthesized L-dihydroxyphenylalanine DOPA and Its Application to Protein Conjugation

Published on: August 24, 2018

7.9K
Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles
07:58

Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles

Published on: November 14, 2018

8.2K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.7K

科学领域:

  • 材料科学 材料科学 材料科学
  • 聚合物化学 聚合物化学
  • 生物材料科学 生物材料科学

背景情况:

  • 聚多巴胺 (PDA) 已知具有表面独立的粘附性,模仿肌结合蛋白.
  • 然而,PDA的刚性骨干与贝的灵活蛋白质序列形成鲜明对比,可能会限制符合性接触和粘附效率.
  • 了解PDA的构建块是优化其粘合性质的关键.

研究的目的:

  • 研究聚多巴胺的构建块在其粘附机制中的特定作用.
  • 阐明PDA普遍粘附的基础上的结合机制.
  • 确定提高PDA粘合性能的策略.

主要方法:

  • 研究了甲基醇和氨基成分对PDA粘附的贡献.
  • 分析了聚多巴胺前体的聚合行为.
  • 使用四分化聚4-乙烯胺 (qPVP) 诱导聚-甲基醇聚合和表面粘附.

主要成果:

  • 由于可溶性极限,而不是特定基质结合,PDA粘附是由不溶性寡合物聚合物的形成开始的.
  • 甲基基组有助于多种结合方式,但氨基基组对于促进粘附所需的不溶性聚合物形成至关重要.
  • 单独的聚乙醇不形成没有氨基的表面涂层;聚合是关键.

结论:

  • 聚多巴胺的普遍粘附主要是由不溶性聚合物的形成驱动的,由氨基团促进.
  • 优化PDA作为粘合剂需要理解和控制这种聚合过程.
  • 这项研究阐明了PDA的粘附机制,将其与鱼灵感的蛋白质区分开来,并提出了合成粘合剂的新设计原则.